PROMUS PREMIER™ China Post-Approval Study
NCT: NCT03273023 · COMPLETED
NCT IDNCT03273023
StatusCOMPLETED
Start Date2018-01-11
Completion2025-10-03
Brief Summary
To compile real-world clinical outcome data for the Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System (Promus PREMIERTM Stent System) in routine clinical practice in China.
Frequently Asked Questions
What is PROMUS PREMIER™ China Post-Approval Study?
PROMUS PREMIER™ China Post-Approval Study is a clinical trial registered under NCT03273023. Current status: COMPLETED.
What is the status of NCT03273023?
The current status of NCT03273023 (PROMUS PREMIER™ China Post-Approval Study) is: COMPLETED.
When did PROMUS PREMIER™ China Post-Approval Study start?
PROMUS PREMIER™ China Post-Approval Study started on 2018-01-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.